Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | HPGD | P15428 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24801442 | 0.97 | ALDH1A1 (0.33) | ALDH1A1HPGDKDM4EMAPTNPSR1 | |
| SCHEMBL17991016 | 0.91 | ALDH1A1 (0.41) | ALDH1A1HPGDKDM4EMAPTNPSR1 | |
| SCHEMBL24801544 | 0.89 | ALDH1A1 (0.33) | ALDH1A1HPGDKDM4EMAPTNPSR1 | |
| SCHEMBL24802377 | 0.88 | KDM4E (0.34) | ALDH1A1HPGDKDM4EMAPTNPSR1 | |
| SCHEMBL24801461 | 0.87 | PRKDC (0.34) | ALDH1A1HPGDKDM4EMAPTNPSR1 | |
| SCHEMBL15497565 | 0.87 | ALDH1A1 (0.43) | ALDH1A1HPGDKDM4EMAPTNPSR1 | |
| SCHEMBL18505465 | 0.87 | ALDH1A1 (0.45) | ALDH1A1HPGDKDM4EMAPTNPSR1 | |
| SCHEMBL24803006 | 0.86 | PRKDC (0.32) | ALDH1A1HPGDKDM4EMAPTNPSR1 | |
| SCHEMBL19961610 | 0.86 | HPGD (0.34) | ALDH1A1HPGDKDM4EMAPTNPSR1 | |
| SCHEMBL21213610 | 0.86 | HPGD (0.37) | ALDH1A1HPGDKDM4EMAPTNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220411411-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING ELEMENT, AND METHOD FOR PRODUCING ORGANIC LIGHT-EMITTING ELEMENT | LT MATERIALS CO.,LTD. (KR) | 2022-12-29 | — | — | US | disclosed |
| WO-2021133016-A2 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING ELEMENT, AND METHOD FOR PRODUCING ORGANIC LIGHT-EMITTING ELEMENT | 엘티소재주식회사 | 2021-07-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220411411-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING ELEMENT, AND METHOD FOR PRODUCING ORGANIC LIGHT-EMITTING ELEMENT | CRY1, ODC1, ORC3 | ALDH1A1 53/4885HPGD 582/4885KDM4E 2970/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.